This has some additional details about the study posted here. I'm confused about the process they're following. They're passing out pills to people they visit at home. Do they have identical-looking placebo packs, and they're tracking who gets what by number or something? Seems dubious.
The investigation, which aims to reduce hospitalizations for Covid-19, has already started with voluntary patients, who received the drug and will now be evaluated for 30 days.
With the team from the Ministry of Public Health, led by Ricardo Cardozo, the Province's investigation began that will show the efficacy of Ivermectin, to prevent hospitalizations of patients with a positive Covid-19 swab.
This initiative is carried out between the Ministry of Public Health of the Province through the Crisis Committee and the Institute of Cardiology "Juana Francisca Cabral" and places the province at the forefront of the fight against the virus. The investigation was presented on August 19 in a ceremony led by Governor Gustavo Valdés.
"The research protocol for the use of Ivermectin is in process, it has already begun and home visits are being made to patients, to whom information is provided, what the entire research protocol consists of and now the first pills were delivered, "said Director General of Epidemiology Angelina Bobadilla.
In this sense, he explained that it is a double-blind study, so "some people receive the medication that contains the active drug, Ivermectin and others, the placebo (inert substance). Morphologically the pills are exactly the same."
"Blood samples are taken to evaluate the status of the patients, vital signs are checked and on the third day there is a new visit where a swab is done. The follow-up is for 30 days," he indicated and remarked that "the admission the protocol is at the will of each person who becomes infected ".
Ivermectin is a drug that is used to treat parasitic diseases, but it was found to have an effect on Covid-19, reducing the viral load.
[-] TrumpLyftAlles | 1 points | Aug 26 2020 04:03:21
This has some additional details about the study posted here. I'm confused about the process they're following. They're passing out pills to people they visit at home. Do they have identical-looking placebo packs, and they're tracking who gets what by number or something? Seems dubious.
The investigation, which aims to reduce hospitalizations for Covid-19, has already started with voluntary patients, who received the drug and will now be evaluated for 30 days.
With the team from the Ministry of Public Health, led by Ricardo Cardozo, the Province's investigation began that will show the efficacy of Ivermectin, to prevent hospitalizations of patients with a positive Covid-19 swab.
This initiative is carried out between the Ministry of Public Health of the Province through the Crisis Committee and the Institute of Cardiology "Juana Francisca Cabral" and places the province at the forefront of the fight against the virus. The investigation was presented on August 19 in a ceremony led by Governor Gustavo Valdés.
"The research protocol for the use of Ivermectin is in process, it has already begun and home visits are being made to patients, to whom information is provided, what the entire research protocol consists of and now the first pills were delivered, "said Director General of Epidemiology Angelina Bobadilla.
In this sense, he explained that it is a double-blind study, so "some people receive the medication that contains the active drug, Ivermectin and others, the placebo (inert substance). Morphologically the pills are exactly the same."
"Blood samples are taken to evaluate the status of the patients, vital signs are checked and on the third day there is a new visit where a swab is done. The follow-up is for 30 days," he indicated and remarked that "the admission the protocol is at the will of each person who becomes infected ".
Ivermectin is a drug that is used to treat parasitic diseases, but it was found to have an effect on Covid-19, reducing the viral load.
permalink